Key July Disclosure Deadlines and Updates
Monthly issueThis month brings three international disclosure deadlines, plus an update on CMS Open Payments data. The summaries below cover who is affected, what is due and where it is filed. Subscribers get the full requirements, source links and submission details for each.
UNITED STATES
CMS Open Payments Data for PY 2025 Coming 7/14
The Program Year (PY) 2025 (January 1, 2025 – December 31, 2025) data is now available for download, and its data summaries are now available for viewing in the Open Payments System. The PY 2025 data will be refreshed in January 2027 to include updates from disputes and other corrections made since the initial publication.
International
South Korea Disclosures Due 7/1 to 7/20
Persons with product approval of pharmaceuticals, importers, pharmaceutical wholesalers or pharmaceutical sales promoters entrusted by persons with product approval of pharmaceuticals, importers and pharmaceutical wholesalers must prepare an expenditure report on the details of economic benefits, etc. provided to pharmacists, herbal pharmacists, medical professionals, founders of medical institutions or employees of medical institutions within three months after the end of each fiscal year and disclose the expenditure report as a part of the annual fact-finding survey under the Pharmaceutical Affairs Act (PAA).
A medical device manufacturer, importer, seller or lessor, or a medical device sales promotion business operator entrusted with medical devices sales or lease promotion duties by a manufacturer, importer, seller or lessor must prepare an expenditure report on the details of economic benefits, etc. provided to medical professionals, founders of medical institutions or employees of medical institutions within three months after the end of each fiscal year and disclose the expenditure report as a part of the annual fact-finding survey under the Medical Devices Act (MDA).
International
Philippines Biannual Disclosures Due 7/15
Under Administrative Order (AO) 2021-0036, all FDA-licensed manufacturers, traders, repackers and distributor-importers and distributor-wholesalers of FDA-registered drugs, medical devices and biological products, including vaccines and medical supplies, must bi-annually declare all financial relationships directly or indirectly made with healthcare professionals (HCPs) or healthcare providers, without limitation of value, to the Philippines Food and Drug Administration (FDA) via their central platform, Online Disclosure Report System (ODRS) by July 15 for the first half of the year.
International
Slovakia Biannual Pharmaceutical Disclosures Due 7/31
Pharmaceutical companies, licensed pharmaceutical care providers, holders of a registration for a human medicinal product, and holders of authorizations for manufacturing of medicinal products or wholesale distribution of medicinal products, must disclose all expenditures on promotion, marketing and monetary and non-monetary benefits granted directly or indirectly to healthcare professionals (HCPs) and healthcare providers to the Slovakian Ministry of Health by the biannual deadline of July 31 via Information System of Health Indicators (ISZI) or web services run by the National Centre for Health Information (NCZI).
Key Date
July 31, 2026
Filing Platform
Information System of Health Indicators (ISZI) | Web Services
About the Newsletter
Why Subscribe
Each edition draws from RegulatoryID, MedPro’s expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead. Sign up and receive:
Monthly Newsletter
A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions
Quick Summaries
Concise high-level summaries in the email so you can quickly scan deadlines and what's required
Detailed Summaries
Linked detailed summaries with full regulatory context, deadlines and reference links
Urgent Alerts
Immediate alerts for urgent developments that cannot wait for the next monthly send
Request Access
Subscribe to RegulatoryID
Enter your work email to request full access to the current edition and to receive ongoing updates direct to your inbox.
Related resources
-
Two International Disclosure Dates to Plan For
Colombia’s biannual value-transfer filing is due September 30, and Japan’s annual disclosure window follows each company’s fiscal year end.
-
One Upcoming International Disclosure Deadline
France’s semiannual Sunshine Act disclosure is due September 1 to the French Ministry of Health. Who is affected, what is due and where it is filed.
-
Midyear Filing Deadlines to Plan For
Ten U.S. and international reporting and registration updates due June 30 and July 1, with who is affected, what is due and where it is filed.
-
Your First Monthly Look at Reporting Requirements
Three U.S. and international annual filing and disclosure updates due May 31 and June 1, with who is affected, what is due and where it is filed.
